Confirmed plenary keynote lectures

Please find below more information about the keynote speakers

*This information will be updated and new speakers will be added.

Prof. Annelien Bredenoord
Ethics of innovative technologies

Prof Annelien L. Bredenoord PhD (1979) is a full professor of Ethics of Biomedical Innovation at the University Medical Center Utrecht and Utrecht University, The Netherlands, as well as member (as of 2015) of the Senate of the Dutch Parliament, on behalf of the political party Democrats 66 (D66). Her political portfolios are health care, ethics, privacy & data protection, and family law.

Her research group seeks to identify, evaluate and promote policies and practices that ensure that biomedical innovation develops in an ethically and socially responsible matter. Recent advances in biological and medical research, such as regenerative medicine and stem cell research, next generation DNA sequencing, genome editing, reproductive technologies, biobanking and Big Data, continuously raise ethical and societal challenges: how to translate biomedical innovations from basic research into clinical care and society in an ethically sound way?

Bredenoord co-authored over 100 articles (published in top journals among which Science, Nature, Nature Cell Biology, Nature Reviews Genetics, BMJ and Plos Medicine) and supervises several PhD students. She obtains funding from among others EU Horizon 2020, KWF (Dutch Cancer Society), NWO Gravitation program and The Netherlands Organization for Health Research and Development ZonMw (among which a personal VENI grant).

Annelien is member of several international committees among which the former Chair of the Ethics Committee of the International Society for Stem Cell Research (ISSCR), member of the Scientific Board of the European Meeting on Psychosocial Aspects of Genetics (EMPAG) and The Hinxton Group. In The Netherlands, she is member of the Young Academy of the Royal Netherlands Academy of Arts and Sciences (KNAW), member of the Board of the Netherlands Organisation for Health Research and Development (ZonMw), the National Indication Committee Pre-implantation Genetic Diagnosis, the L’Oréal UNESCO: For Women in Science Award Committee, and UMC Utrecht’s Research Ethics Committee (IRB).

She is frequently invited in Dutch popular media to discuss the ethical aspects of biomedicine.
Twitter: @albredenoord
Website (in Dutch):

Dr. Jason Ekert
Novel 3R technologies in early drug discovery

Biography and picture will be added later.

Dr. Don Ingber
Novel non‐animal technologies in disease mechanisms (microphysiological systems, organoids and Organ‐on‐a‐Chip)

Biography and picture will be added later.

Prof. Dr. Malcolm MacLeod
Data quality in translational research

Biography and picture will be added later.

Dr. Russel Thomas
Computational systems toxicology-real world evidence

Russell Thomas is the director of the Center for Computational Toxicology and Exposure at the U.S. Environmental Protection Agency. The Center is performing solutions-driven research to rapidly evaluate the potential human health and environmental risks due to exposures to environmental stressors and ensure the integrity of the freshwater environment and its capacity to support human well-being. Dr. Thomas has a broad, multidisciplinary background and experience.

Dr. Thomas’ formal academic training includes a B.A. in chemistry from Tabor College, an M.S. in radiation ecology and health physics from Colorado State University, and a Ph.D. in toxicology also at Colorado State. Following his doctoral studies, Dr. Thomas performed postdoctoral research in molecular biology and genomics at the McArdle Cancer Research Laboratory at the University of Wisconsin. Following his academic training, Dr. Thomas performed bioinformatics and genomics research in the biotechnology sector and gained experience in high-throughput screening and in vitro assay development in the biopharma sector.

Prior to coming to the U.S. EPA, Dr. Thomas worked as an investigator and senior manager at a non-profit research institute.